Both Mounjaro and Wegovy are cleared for weight loss in combination with ... vaccines to adults aged 50-64 9:39 AM UTC ...

Type 2 diabetes is a risk factor for dementia and Alzheimer’s. Novo Nordisk, which makes Ozempic and Wegovy, is running two ...

While the regulator has not approved their use in type 1 diabetes, off-label prescribing for GLP-1 receptor agonists has ...

The full-year cost of care for U.S. patients with obesity two years after starting on Novo Nordisk's Wegovy or similar GLP-1 drugs was $18,507, on average. That represents a 46% jump over the average ...

This week, Novo Nordisk, the Copenhagen, Denmark based pharmaceutical company, asked the US Food and Drug Administration (FDA ...

The active ingredient in Ozempic was associated with a 40% to 70% lower risk of a first-time Alzheimer’s diagnosis in ...

Patients taking Novo Nordisk A/S’s Ozempic were at significantly reduced risk of being diagnosed with Alzheimer’s, according ...

Nearly 7 million Americans 65 and older are living with Alzheimer’s disease, which gradually destroys memory and thinking ...

The full-year cost of care for U.S. patients with obesity two years after starting on Novo Nordisk’s Wegovy or similar GLP-1 ...

A mong the many newcomers to the business of weight-loss drugs is Hims & Hers, an American e-pharmacy better known for ...

Early man first invented tools. Then he invented jewellery. Archeologists have discovered strings of shells, believed to have ...

Boxes of Wegovy made by Novo Nordisk are seen at a pharmacy in London, Mar. 8, 2024. Hollie Adams/Reuters Semaglutide was associated with a 70% reduced risk when compared with insulin and 40% reduced ...